WeVote
Log In

Bill

Bill

HB 193

HEALTH/SICKLE CELL ANEM: Provides for the membership of the Sickle Cell Commission

2026 Regular Session Introduced by Tammy Phelps

HB 193 restructures Louisiana's Sickle Cell Commission membership and appointment procedures to modify governance of the state's sickle cell disease advisory body.

Effective date: 08/01/2026.
0
WeVote Research Nonpartisan
Bill Summary · HB 193

Legislative bill overview

HB 193 modifies the composition and membership structure of Louisiana's Sickle Cell Commission by adjusting who serves on the board and how members are appointed. The bill updates administrative and governance provisions for this state commission dedicated to addressing sickle cell disease issues.

Why is this important

Sickle cell disease disproportionately affects African American populations, and Louisiana has higher prevalence rates than many states. The commission's structure determines its effectiveness in advocating for research, treatment access, and patient support services. Proper board composition ensures the commission can adequately represent stakeholders and communities most impacted by the disease.

Potential points of contention

  • Representation concerns: Changes to membership composition could either improve or dilute representation of affected communities, patients, and medical professionals depending on which positions were modified
  • Appointment authority: Shifts in who appoints commissioners (legislature, governor, medical boards, etc.) may affect the commission's independence and responsiveness to affected populations
  • Scope and resources: Structural changes don't address whether the commission has adequate funding and authority to implement meaningful health initiatives

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.